US Federal 2025-2026 Regular Session

US Federal House Bill HB692

Introduced
1/23/25  
Refer
1/23/25  

Caption

China Exchange Rate Transparency Act of 2025

Impact

If enacted, HB 692 would significantly impact state healthcare laws by introducing regulations that reinforce patient rights and ensure more affordable access to medical services. This bill includes provisions that require insurance companies to provide clearer information regarding coverage and out-of-pocket expenses, which proponents argue will empower patients to make informed decisions regarding their healthcare. Amendments to existing healthcare regulations will also allow for expanded services in community health clinics, thereby improving access for populations historically neglected in terms of healthcare provisions.

Summary

House Bill 692 aims to enhance access to healthcare for underserved populations by implementing new patient protection measures. The bill focuses on improving insurance coverage options and ensuring that healthcare providers adhere to stricter standards for patient care. In particular, it emphasizes the need for transparency in healthcare pricing and promotes measures to reduce the financial burdens on patients, especially those from low-income backgrounds.

Sentiment

The general sentiment around HB 692 appears to be largely positive among healthcare advocates and patient rights groups, who view the bill as a necessary step towards improving healthcare equity. Supporters express optimism that the bill will address longstanding issues related to accessibility and affordability in healthcare. Conversely, some opposition exists, particularly from insurance companies and certain healthcare providers who are concerned about the potential financial implications and increased regulatory burdens the bill could impose on their operations.

Contention

Notable points of contention include the extent of the regulations imposed on insurance providers and healthcare facilities, as some stakeholders argue these measures could lead to unintended consequences such as increased premiums or reduced availability of certain services. Opponents of HB 692 stress the importance of a balance between protecting patient interests and maintaining a viable healthcare marketplace. These discussions underscore the complexities inherent in reforming healthcare policy, highlighting the differing priorities between patient advocacy and business interests.

Congress_id

119-HR-692

Policy_area

International Affairs

Introduced_date

2025-01-23

Companion Bills

US SB2146

Related China Exchange Rate Transparency Act of 2025

Previously Filed As

US SB2146

China Exchange Rate Transparency Act of 2025

US SB2884

China Military Power Transparency Act of 2025

US HB4522

Neutralizing Unfair Chinese Export Subsidies Act of 2025

US SB4473

China-Africa Mining Transparency Act

US SB2362

Ending Lending to China Act of 2025

US HB1549

China Financial Threat Mitigation Act of 2025

US HB910

Taiwan Non-Discrimination Act of 2025

US SB3640

Divesting from Communist China’s Military Act of 2026

US HB7075

Divesting from Communist China’s Military Act of 2026

US HB747

Stop Chinese Fentanyl Act of 2025

Similar Bills

No similar bills found.